眼保健品市場、機會、成長動力、產業趨勢分析與預測，2024-2032

2023 年，全球眼保健補充劑市場價值為26 億美元，預計2024 年至2032 年複合年成長率為7.3%。必需營養素，和 omega-3 脂肪酸，旨在保護眼睛免受氧化壓力，改善視力，並減少黃斑部病變和乾眼症等與年齡相關的疾病。白內障、屈光不正、AMD 和青光眼等眼部疾病的增加推動了市場的成長。世界衛生組織在 2023 年報告稱，全球有 22 億人患有視力障礙，其中 10 億人患有屈光不正和白內障。這增加了眼保健補充劑的採用，以支持視力健康。其他成長因素包括螢幕時間增加、產品交付技術的進步以及老年人口的成長。

整個眼保健品產業根據成分類型、適應症、配方、配銷通路和地區進行分類。

細分市場包括抗氧化劑、葉黃素和玉米黃素、omega-3脂肪酸、類黃酮、α-硫辛酸、輔酶Q10、蝦紅素等。預計到 2032 年，葉黃素和玉米黃質市場將達到 15 億美元。這些類胡蘿蔔素集中在黃斑部中，保護其免受氧化壓力，並可能降低 AMD 風險。它們具有抗炎特性，可減少眼部發炎並支持眼部健康。它們的抗氧化特性支持長期眼睛健康，推動市場成長。

據指示，該市場包括白內障、眼瞼結膜炎、AMD、青光眼、角膜支持、眼部疲勞等。 2023 年，AMD 細分市場的銷售額為 7.802 億美元。補充葉黃素、玉米黃質、維生素 C 和 E 以及鋅有助於黃斑部健康。抗氧化劑可以中和自由基，有可能減緩 AMD 的進展。抗發炎補充劑可減少視網膜炎症，支持眼睛健康並推動 AMD 相關補充劑的需求。

預計到 2032 年，美國眼保健補充劑市場將達到 18 億美元。在人口老化、螢幕時間增加和預防性健康關注的推動下，人們對眼睛健康的認知不斷提高，刺激了對眼睛健康補充劑的需求。此外，老年性黃斑部病變 (AMD) 和白內障等疾病的日益普及進一步推動了對旨在保護視力的補充劑的需求。此外，補充劑配方的創新，包括添加抗氧化劑和 omega-3 脂肪酸，正在吸引注重健康的消費者。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 眼部疾病盛行率增加
    • 螢幕活躍時間成長
    • 產品交付技術的進步
    • 老年人口不斷增加
  • 產業陷阱與挑戰
    • 高級補充劑相關的高成本
    • 潛在的副作用
• 成長潛力分析
• 監管環境
• 技術景觀
  • 核心技術
  • 鄰近技術
• 2023 年定價分析
  • 按地區
  • 按關鍵人物
• 未來市場趨勢
• 管道分析
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按成分類型，2021 - 2032

• 主要趨勢
• 葉黃素和玉米黃質
• 抗氧化劑
• Omega-3 脂肪酸
• 輔酶Q10
• 黃酮類化合物
• α-硫辛酸
• 蝦紅素
• 其他成分類型

第 6 章：市場估計與預測：按指標分類，2021 - 2032 年

• 主要趨勢
• 老年黃斑部病變（AMD）
• 白內障
• 青光眼
• 眼睛疲勞
• 角膜支撐
• 眼瞼結膜炎
• 其他適應症

第 7 章：市場估計與預測：按配方分類，2021 - 2032 年

• 主要趨勢
• 片劑/膠囊
• 液體
• 凝膠
• 軟糖
• 粉末

第 8 章：市場估計與預測：按配銷通路，2021 - 2032 年

• 主要趨勢
• 醫院藥房
• 零售藥房
• 網路藥房

第 9 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 10 章：公司簡介

• Alcon Inc.
• Alliance Pharma plc
• Bausch Health Companies Inc.
• Bluebonnet Nutrition
• Basic Brands Inc.
• Herbalife Ltd.
• Healthy Origins USA
• NusaPure
• Nordic Naturals
• Nestle S.A.
• Nutrivein
• Pfizer, Inc.
• Prestige Consumer Healthcare Inc.
• Vitabiotics Ltd.
• ZeaVision LLC

The Global Eye Health Supplements Market was valued at USD 2.6 billion in 2023 and is projected to grow at a 7.3% CAGR from 2024 to 2032. These supplements, containing essential nutrients like vitamins A, E, and C, zinc, zeaxanthin, lutein, and omega-3 fatty acids, aim to protect eyes from oxidative stress, improve vision, and reduce age-related conditions such as macular degeneration and dry eye syndrome. Rising eye disorders, including cataracts, refractive errors, AMD, and glaucoma, drive market growth. The WHO reported in 2023 that 2.2 billion people globally had vision impairment, with 1 billion affected by refractive errors and cataracts. This has increased the adoption of eye health supplements to support vision health. Additional growth factors include increased screen time, advancements in product delivery technologies, and a growing geriatric population.

The overall eye health supplements industry is classified based on the ingredient type, indication, formulation, distribution channel, and region.

The market segments include antioxidants, lutein and zeaxanthin, omega-3 fatty acids, flavonoids, alpha-lipoic acid, coenzyme Q10, astaxanthin, and others. The lutein and zeaxanthin segment is forecasted to reach USD 1.5 billion by 2032. Lutein and zeaxanthin filter harmful blue light, reducing digital eye strain and protecting the retina. These carotenoids are concentrated in the macula, protecting it from oxidative stress and potentially lowering AMD risk. They possess anti-inflammatory properties, reducing eye inflammation and supporting ocular health. Their antioxidant properties support long-term eye health, driving market growth.

By indication, the market includes cataracts, eyelid conjunctivitis, AMD, glaucoma, corneal support, eye fatigue, and others. The AMD segment accounted for USD 780.2 million in 2023. AMD affects the macula, crucial for sharp vision. Supplements with lutein, zeaxanthin, vitamins C and E, and zinc support macular health. Antioxidants neutralize free radicals, potentially slowing AMD progression. Anti-inflammatory supplements reduce retinal inflammation, supporting eye health and driving demand for AMD-related supplements.

The U.S. eye health supplements market is projected to reach USD 1.8 billion by 2032. The U.S. has a developed healthcare system with advanced research facilities, clinical trials, and FDA regulation, ensuring high-quality supplements. Increased awareness about eye health, driven by aging populations, high screen time, and preventive health focus, fuels demand for eye health supplements. Additionally, the growing prevalence of conditions such as age-related macular degeneration (AMD) and cataracts is further driving the need for supplements aimed at preserving vision. Furthermore, innovations in supplement formulations, including the incorporation of antioxidants and omega-3 fatty acids, are attracting health-conscious consumers.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of eye disorders
    • 3.2.1.2 Growth in active screen time
    • 3.2.1.3 Advancements in product delivery technologies
    • 3.2.1.4 Rising geriatric population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High costs associated with advanced supplements
    • 3.2.2.2 Potential side effects
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
  • 3.5.1 Core technologies
  • 3.5.2 Adjacent technologies
• 3.6 Pricing analysis, 2023
  • 3.6.1 By region
  • 3.6.2 By key player
• 3.7 Future market trends
• 3.8 Pipeline analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Ingredient Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Lutein and zeaxanthin
• 5.3 Antioxidants
• 5.4 Omega-3 fatty acids
• 5.5 Coenzyme Q10
• 5.6 Flavonoids
• 5.7 Alpha-lipoic acid
• 5.8 Astaxanthin
• 5.9 Other ingredient types

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Age-related macular degeneration (AMD)
• 6.3 Cataract
• 6.4 Glaucoma
• 6.5 Eye fatigue
• 6.6 Corneal support
• 6.7 Eyelid conjunctivitis
• 6.8 Other indications

Chapter 7 Market Estimates and Forecast, By Formulations, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Tablet/capsule
• 7.3 Liquid
• 7.4 Gels
• 7.5 Gummies
• 7.6 Powder

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospital pharmacy
• 8.3 Retail pharmacy
• 8.4 Online pharmacy

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Alcon Inc.
• 10.2 Alliance Pharma plc
• 10.3 Bausch Health Companies Inc.
• 10.4 Bluebonnet Nutrition
• 10.5 Basic Brands Inc.
• 10.6 Herbalife Ltd.
• 10.7 Healthy Origins USA
• 10.8 NusaPure
• 10.9 Nordic Naturals
• 10.10 Nestle S.A.
• 10.11 Nutrivein
• 10.12 Pfizer, Inc.
• 10.13 Prestige Consumer Healthcare Inc.
• 10.14 Vitabiotics Ltd.
• 10.15 ZeaVision LLC